Jian-ya Lin

PharmD

Pharmacy Management Consultant

Brookfield, WI, US

Main +1 262 784 2250 | Office +1 262 201 0423

Jian-ya Lin is a pharmacy management consultant working from the Milwaukee office of Milliman. She joined the firm in 2023.

Download bio

Loading component...

Experience

Jian-ya’s experience includes over 10 years working with health plans and PBMs.

Prior to joining Milliman, Jian-ya worked in various clinical and account leadership positions within a PBM subsidiary of a large Blue plan. Her specialties include Medicare formulary management and strategy and EGWP RFPs, sales strategies, account retention, and implementation.

Publications and Presentations

Co-author, Battle royale: Part D EGWPs vs RDS plans in the era of the Inflation Reduction Act. Millman White Paper, February 2024.
Co-author, Potential IRA interactions with Medicare Part D Risk Adjustment: Calibration Data Timing Considerations. Milliman White Paper, November 2023.

Education

PharmD, University of California, San Francisco

Loading component...

Publications

Read their latest work

Article

Prescribing a Part D formulary for the new IRA world

13 December 2024 - by Madeleine Feller, Justin Harris, Jian-ya Lin, Mark F. Gruenhaupt, RPh

Medicare Part D: We highlight the changes in plan incentives and key trends in 2025 formulary coverage, along with considerations for 2026.

Article

Battle royale: Part D EGWPs vs. RDS plans in the era of the Inflation Reduction Act

13 February 2024 - by Matthew Dickett, Jian-ya Lin, Todd Wanta

The Inflation Reduction Act redefines Medicare Part D, so we highlight key factors plan sponsors should consider when evaluating options for retiree benefits.

Article

Potential IRA interactions with Medicare Part D Risk Adjustment: Calibration Data Timing Considerations

07 November 2023 - by Michelle (Klein) Robb, Jian-ya Lin

Regarding the Inflation Reduction Act’s potential effects on the Medicare Part D risk adjustment, we offer additional thoughts on calibrating the 2025 model.

Jian-ya Lin

Loading component...

Experience

Loading component...

Read their latest work

Prescribing a Part D formulary for the new IRA world

Battle royale: Part D EGWPs vs. RDS plans in the era of the Inflation Reduction Act

Potential IRA interactions with Medicare Part D Risk Adjustment: Calibration Data Timing Considerations

CHOOSE A LOCATION AND LANGUAGE

Jian-ya Lin

Experience

CHOOSE A LOCATION AND LANGUAGE